Skip to main content

$0.155 0.005 (3.33%)

High

$0.16

Low

$0.15

Trades

7

Turnover

$4,468

Volume

29,243
30 June 2023 at 3:01pm
Register to track FRE and receive email alerts.

Nasodine COVID-19 Trial Concludes Recruitment

StockBot

416,823 posts

FRE released this announcement to the ASX on 3 April 2023, 9:40. The announcement is marked as price sensitive, and is 3 page(s) in length and 325.78kb in size.

You can view all announcements from FRE and see how they appear on a price chart on the announcements page.

At the date of this announcement, FRE was 0.006% short sold according to ASIC data. It was ranked the 577th most shorted stock on the ASX. It remains ranked 620th as of the latest reported data (14 July 2025).

Other Recent Announcements from FRE
Firebrick Update on AAT Schedule 29 June 2023, 16:23
Cleansing Notice 21 June 2023, 14:38
Change of Director's Interest Notice - Stephen Goodall 21 June 2023, 14:36
Nasodine COVID-19 Trial Concludes Recruitment 3 April 2023, 9:40
Cleansing Notice 28 March 2023, 14:14
Application for quotation of securities - FRE 28 March 2023, 14:11
Firebrick Pharma's Phase 3 Trial of Nasodine Resumes 21 March 2023, 8:42
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track FRE and receive email alerts.